Cita APA

van Dijk, E., Smeenk, M., Bensch, F., Sadowksa, A., Verschueren, M., Verhaert, M., . . . Verheijden, R. (2026). Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer.

Citación estilo Chicago

van Dijk, EJ, et al. Checkpoint Inhibitor Effectiveness After Corticosteroids and Second-line Immunosuppressants for Immune-related Adverse Events in Non-small-cell Lung Cancer. 2026.

Cita MLA

van Dijk, EJ, et al. Checkpoint Inhibitor Effectiveness After Corticosteroids and Second-line Immunosuppressants for Immune-related Adverse Events in Non-small-cell Lung Cancer. 2026.